-
Signature
-
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
-
Issuer symbol
-
ANIP
-
Transactions as of
-
09 May 2025
-
Transactions value $
-
-$53,781
-
Form type
-
4
-
Filing time
-
13 May 2025, 16:21:52 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Shanmugam Muthusamy |
HEAD OF R&D, COO-NOVITIUM OPS, Director |
C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE |
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook |
13 May 2025 |
0001870913 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ANIP |
Common Stock |
Sale |
-$53.8K |
-700 |
-0.11% |
$76.83 |
632K |
09 May 2025 |
Held by Esjay LLC |
F1, F2, F3 |
| holding |
ANIP |
Common Stock |
|
|
|
|
|
92.6K |
09 May 2025 |
Direct |
|
| holding |
ANIP |
Common Stock |
|
|
|
|
|
5K |
09 May 2025 |
Held by SS Pharma LLC |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: